Sign In
Upcoming Event
Free Newsletter
New leader takes the helm at Henrietta-based medical device manufacturer
New leader takes the helm at Henrietta-based medical device manufacturer
Listen to this articleTurbett Surgical has named medical device industry vet Kevin Danahy as president and CEO.
He succeeds Bill Dubiel, who held the position from late 2024, and Mike Zimmer, who served prior to that.
“Turbett Surgical represents a strong fit for my leadership experience, combining technical innovation with significant opportunity for growth,” Danahy said. “I look forward to working with the team to accelerate growth and better serve surgeons, nurses, sterile processing professionals and hospital systems worldwide.”
Danahy has more than two decades of leadership in the sector, most recently serving at California-based Pulse Biosciences, where he held key executive roles, including president and CEO, during a pivotal transition as the company sharpened its focus on cardiac and oncology applications.
Previously, he was president and CEO of private equity-backed Solmetex, a Massachusetts firm, where he rebuilt the executive leadership team and led the company to a successful exit.
“Kevin brings a track record of building high-growth, customer-focused organizations to Turbett, and we believe his experience will strengthen the company’s mission to expand the U.S. and international reach of its innovative product,” said Joe Siletto, co-managing partner of J.P. Morgan Life Sciences Private Capital and chairman of the board at Turbett. “He has demonstrated the ability to build strong teams while maintaining a focus on customer needs and patient outcomes.”
Turbett Surgical, a Henrietta-based medical device manufacturer, produces the patented Turbett Pod system, which is used in operating rooms to sterilize surgical instruments.
[email protected] / (585) 653-4021
=
